Bionpharma recalls
FDA enforcement reports naming Bionpharma Inc. as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 1
- Most recent report
- Sep 9, 2026
- Sep 9, 2026Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count…Drug · Bionpharma Inc.Presence of Foreign Tablets/CapsulesClass III
- Jul 29, 2026Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, D…Drug · Bionpharma Inc.Presence of Foreign Tablets/CapsulesClass II
- Oct 23, 2024Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bi…Drug · Bionpharma Inc.Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.Class I
- Jul 31, 2019Clobazam Oral Suspension, 2Drug · Bionpharma Inc.Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.Class II